report cross-country comparisons that: (i) focus on 11 therapeutic classes experiencing patent expiration and loss of …

sufficiently better at judging an idea's value and if it is sufficiently more costly to patent low than high value ideas, VCs …-run performance, but also infl ates their acquisition prices, and lowers their acquirers' overall profits. Patent law usefulness …

pharmaceuticals. We challenge this orthodox view and show, to the contrary, that the pace of innovation often is faster in a world …

pharmaceuticals, specifically drug reformulation regulatory gaming. …

This paper addresses the relationship between patent protection and investment in the development of new pharmaceutical … Trade Organization, has increased levels of patent protection around the world. Since patents also have the potential to … patent laws and the severity of disease, we test the hypothesis that increased patent protection results in greater drug …

creating an internal market for pharmaceuticals can be analysed. In a model of third-degree price discrimination, arbitrage … Market in pharmaceuticals are ambiguous, since a movement from segmented and price-controlled markets towards integrated …

acting on their behalf such as insurers and governments) to spend on their treatment during the patent lifetime. We find … mean market size an additional $1.8 billion is required in additional patent life revenue to induce the invention of one … the hypothesis that innovation in pharmaceuticals is becoming more difficult and expensive over time, as costs of …